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Abstract
A high-throughput screening method has been developed which enables functional analysis of bacteriorhodpsin in whole cell pastes.
Reflectance spectra, from as little as 5 ml of Halobacterium salinarum cells, show close correspondence to that obtained from the purified
purple membrane (PM), containing bacteriorhodopsin (BR) as the sole protein component. We demonstrate accurate quantification of BR
accumulation by ratiometric analysis of BR (Amax 568) and a membrane-bound cytochrome (Amax 410). In addition, ground-state light- and
dark-adapted (LA and DA, respectively) spectral differences were determined with high accuracy and precision. Using cells expressing the
BR mutant D85N, we monitored transitions between intermediate-state homologues of the reprotonation phase of the light-activated proton
pumping mechanism. We demonstrate that phenotypes of three mutants (D85N/T170C, D85N/D96N, and D85N/R82Q) previously
characterized for their effect on photocycle transitions are reproduced in the whole cell samples. D85N/T170C stabilizes accumulation of the
N state while D85N/D96N accumulates no N state. D85N/R82Q was found to have perturbed the pKa of M accumulation. These studies
illustrate the correspondence between pH-dependent ground-state transitions accessed by D85N and the transitions accessed by the wild-type
protein following photoexcitation. We demonstrate that whole cell reflectance spectroscopy can be used to efficiently characterize the large
numbers of mutants generated by engineering strategies that exploit saturation mutagenesis. D 2002 Elsevier Science B.V. All rights
reserved.
Keywords: Bacteriorhodopsin; Halobacterium salinarum; Conformational equilibrium; Reflectance spectroscopy; High-throughput screening
1. Introduction
Bacteriorhodopsin (BR) is a light-activated proton pump
expressed by the halophilic Archaeon, Halobacterium sal-
inarum [1]. Owing to numerous experimental advantages,
BR is one of the most extensively characterized membrane
proteins. BR accumulates at very high levels in H. salina-
rum, up to 15 mg/l of cell culture [2,3]. At these levels of
expression, wild-type BR forms specialized membrane
patches referred to as purple membrane (PM), in which
BR is the only protein [2]. The PM can constitute up to 50%
of the H. salinarum membrane. The high protein-to-lipid
ratio of PM causes these membrane patches to have a higher
buoyant density than that of the surrounding membrane, and
it can therefore be purified from the remaining membrane
fraction by sucrose density centrifugation [2]. In addition,
the packing of BR into PM results in the formation of two-
dimensional crystalline lattices in vivo [4].
The ground-state structure of BR has been solved to
atomic resolution and demonstrates that the tertiary structure
is composed of seven a-helical transmembrane segments,
with an extracellular amino terminus and a cytoplasmic
carboxyl terminus [5–9]. An aldehyde of vitamin A (retinal)
is covalently coupled to the q-amino group of lysine 216, in
the middle of the seventh helix, via a Schiff base linkage.
Upon absorption of a photon, the retinal undergoes isomer-
ization from the all-trans to the 13-cis configuration [10]
initiating a series of conformational changes that are coupled
to the protonation and deprotonation of key amino acid
residues. As the protein undergoes structural rearrangement,
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the electrogenic environment of retinal changes, altering
the spectral characteristics of BR. Using ground-state and
time-resolved visible absorbance spectroscopy, seven
spectrally distinct intermediates of BR have been identi-
fied (BR568! JXK630XL550XM1412!M2412XN550X
O640!BR568) and the transitions between them extensively
characterized [10–15]. Completion of the photo-induced
structural transitions results in translocation of protons from
the intracellular to the extracellular surface of the membrane
[16]. Proton translocation produces an electrochemical gra-
dient that is utilized for energy requiring cellular processes
[17,18].
Proton pumping by BR can be divided into two phases,
the deprotonation phase (BR through M1) and the reproto-
nation phase (M2 through BR), based on the accessibility
of the Schiff base. Structural changes that determine the
Schiff base accessibility occur in the M1!M2 transition
[14,19,20] and involve rearrangement of the F and G helices
[8,9,21]. The protonation-state of Asp-85 plays a central
role in the conformational changes and linked proton move-
ments. D85 is protonated (from the Schiff base) during the
formation of the M intermediate and remains protonated in
the N and O intermediates [22–24]. Proton transfer from
D85 to the proton release group (PRG) is the rate-limiting
step in the O!BR transition of the photocycle [25].
Replacement of D85 with Asn (D85N) results in a protein
that undergoes structural changes that regulate the pKa’s of
D96 and the Schiff base in a manner consistent with that
observed in the reprotonation phase of the wild-type protein.
In the absence of photoexcitation, three spectrally distinct
species exist in equilibrium and their accumulation is
regulated by pH. At neutral pH, the protein exists, almost
exclusively, in an O-like species (kmax = 615 nm). As the pH
is raised, two additional chromophoric species, an N-
(kmax = 570 nm) and an M-like species (kmax 410 nm), are
increasingly populated [26]. Resonance Raman, FTIR and
X-ray diffraction have confirmed that the transitions in
D85N involve the same chromophore isomerizations
[24,27] and structural changes [23,27], which occur in the
wild-type protein during the M X N and N X O transitions.
D85N is thus a useful system for probing the BR reproto-
nation mechanism.
Predicting the intermolecular interactions that regulate
the conformational changes coupled to proton movement
requires, at a minimum, detailed understanding of the
molecular interactions of all structural states. Atomic level
structures are known for the BR and M states [6,8,9,21] and
lower resolution structures are available for the K and N
states [28,29]. These structures illustrate the amino acid
interactions that change during structural transitions. Under-
standing how side-chain movements regulate the pKa’s of
critical proton binding and release sites requires molecular
engineering and biophysical characterization. Much pro-
gress has been made in this regard via the use of site-
directed mutagenesis [30], but this analysis is incomplete.
An alternative approach is to utilize strategies that enable
screening for interesting second-site mutations generated by
the techniques of scanning, random mutagenesis, and in
vitro molecular evolution [31]. While the fortuitous forma-
tion of the PM has facilitated the purification and structural
analysis of site-directed mutants, this protocol would be
prohibitively time-consuming when coupled with saturation
mutagenesis. To address this limitation, we have developed
an efficient high-throughput spectroscopic screening
method that will expedite characterization of large numbers
of mutants. Our approach uses reflectance spectroscopy of
whole cell samples and avoids the requirement for BR
purification.
2. Materials and methods
2.1. Bacterial strains
The Escherichia coli strain used was DH5a (F , recA1,
endA1, gyrA96, thi1, hsdR17 (r k, mk
+ ), supE44, l ). The
H. salinarum strain used was L33 (Vac , Rub , BR  ;
[18]).
2.2. Media and growth conditions
All salts and chemicals were reagent-grade. Bacteriolog-
ical peptone was from Oxoid, Unipath (Hampton, England),
yeast extract tryptone, Lennox Broth, and Bacto-Agar were
from Difco Laboratories (Detroit, MI). Complex haloarch-
aeal medium was basal salts plus peptone [32]. H. salinarum
cells were transformed as described previously [33]. Selec-
tive media included 10–25 AM mevinolin (gift from Merck,
Sharp and Dohme, Rathaway, NJ). Growth of H. salinarum
cultures was monitored using a Beckman DU-40 spectro-
photometer at k660. Complex E. coli medium was LB
medium or TY medium. E. coli cells were transformed by
Hanahan’s high efficiency calcium shock method [34].
Selective media included 50 Ag/ml ampicillin (Sigma, St.
Louis, MO). E. coli and H. salinarum cells were grown at
37 jC in a New Brunswick G25 shaking incubator (Edison,
NJ) at 225 rpm.
2.3. Reagents
All restriction enzymes and DNA-modifying enzymes
were from New England BioLabs, (Beverly, MA). Custom
oligo-deoxynucleotides were synthesized by GIBCO Life
Technologies (Rockville, MD), Taq Polymerase and deox-
ynucleotide triphosphates were from Perkin Elmer (Nor-
walk, CT) and Pfu Polymerase was from Stratagene (La
Jolla, CA). Wizard DNA miniprep kit was from Promega
Corporation (Madison WI), Qiaquick PCR purification kit
was from Qiagen (Valencia, CA) and Freeze ’n Squeeze
DNA gel extraction spin columns were from Bio-Rad
(Hercules, CA). Electrophoresis grade agarose was from
FMC Corporation (Rockland, ME).
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2.4. Mutagenesis
Construction of the expression vectors containing wild-
type BR and BR containing the D85N mutation has been
described previously [26]. The D85N/T170C mutant was
generated using in vitro gene assembly [31] described
elsewhere [45].
Two second-site mutants, R82Q and D96N, were intro-
duced into the D85N background by PCR mutagenesis.
Using the pENDS:D85N vector as a template, oligos 1 and 2
(Table 1) were used to amplify a DNA fragment containing
both the D85N and R82Q mutations. The product was
digested with BamHI and ApaI, purified and ligated to
create the pENDS:R82Q vector. In addition to generating
the R82Q mutation, oligo 1 destroys the BssHII site present
in the D85N gene but creates a new silent restriction site
ApaI at amino acid positions 80–82. Successful cloning was
confirmed by restriction digest analysis.
The D96N mutant [35] was cloned on a KpnI/NotI frag-
ment into pENDS bop I [36]. Using pENDS bop I:D96N as a
template, oligos 2 and 3 (Table 1) were used to amplify a
DNA fragment containing both the D85N and D96N muta-
tions. Along with the D96N mutation, the DNA template
introduces the silent restriction site SpeI within the codons
for amino acids 99 and 100. Oligo 3 introduces the D85N
mutation and the silent restriction site, BssHII, within the
codons for amino acids 81 and 82. The product was digested
with BamHI and BssHII, purified, and ligated into the
pENDS:D85N vector. Desired clones were identified by
restriction analysis.
Each of the pENDS vectors containing the BR mutants
was digested with PstI and BamHI. The 1.2-kb fragment
containing the bacterio-opsin (bop) gene was subcloned
into the H. salinarum shuttle vector, pUBP2 [37], to
generate pHex expression vectors. Positive clones were
confirmed by restriction digests. DNA (1.5 Ag) for each of
the pHex vectors containing the desired mutations was
dried in a Savant Speed-Vac (Holbrook, NY) and resus-
pended in 15 Al of Spheroplasting Solution (0.5 M EDTA,
2 M NaCl, 27 mM KCl, 50 mM Tris–HCl, 15% sucrose)
for transformation into H. salinarum. Following isolation
of positive transformants, the bop gene was obtained by
PCR from H. salinarum cell lysates and confirmed by
DNA sequencing.
2.5. Cellular screen
H. salinarum cultures expressing the BR constructions
were grown to late stationary phase of growth in 5 ml Rich
Halo Media containing 10 AM mevinolin. Cultures were
pelleted and resuspended in 1 ml of basal salts. Four 200-Al
aliquots of cell suspension were transferred to a nylon
membrane (Hybond N, Amersham) using a vacuum mani-
fold, designed in-house for this purpose. To prevent crystal
formation upon drying, salt was removed from the mem-
brane by equilibrating with deionized water three times.
While this procedure likely lysed the H. salinarum cells, the
resultant whole cell pastes (e.g. total membrane and cyto-
plasmic fractions) were retained on the membrane. Equili-
bration was accomplished by immersing a blotting pad
(VWR, So. Plainfeild, NJ) in water (or buffer, see below)
such that the blotting pad was thoroughly wet, but not
submerged. Nylon membranes were placed, sample side
up on the blotting pad for 15 min. Cell samples were
subsequently equilibrated in titration buffer (100 mM NaCl,
20 mM 3-[cyclohexylamino]-1-propane-sulfonic acid
(CAPS), 20 mM bis tris–propane (BTP), 40 mM NaH2PO4)
at pH 7.5, 9.0, and 10.5. The pH of the nylon membranes
was checked with pH paper. Samples were allowed to dry at
room temperature for 1 h before spectra were collected.
Spectra were recorded at the reflectance port of an RSA 150
integration sphere (Labsphere, North Sutton, NH) coupled
to a PE E18 UV/Vis spectrophotometer (Perkin Elmer).
Four spectra (350 to 800 nm) were recorded of each sample.
Spectra were normalized to 0.000 A at 750 nm and
smoothed using a 10-point moving average. kmax values
were determined using the Perkin Elmer UV WinLab
software’s peak finder function. The kmax at each pH value
was reported as an average of the kmax values determined for
the four spectra. The N/O peak heights were determined by
plotting one normalized spectrum from each pH value on
the same graph and measuring from the kmax to the baseline.
Percent changes were reported relative to the peak height
measured at pH 7.5.
2.6. Purification of BR mutants
H. salinarum cultures expressing the BR mutants were
grown from single colonies in 5-ml cultures with 10 AM
mevinolin. Following three subcultures, a 50-ml culture
with mevinolin was inoculated and grown to midlog phase
(OD660 0.5–0.7). This culture was used to inoculate a 1.5-l
culture to an OD660 of 0.01. Cells were harvested, lysed, and
BR purified as described previously [26]. Purified mem-
branes were stored at  70 jC in titration buffer containing
25% sucrose.
2.7. Spectra of purified D85N:cysteine mutants
Purified high-density membranes were pelleted and
washed three times in titration buffer at pH 7.2. Resus-
pended membranes were dark-adapted (DA) for at least 16 h
at 4 jC prior to titration. All subsequent manipulations were
performed under dim red light. Absorbance spectra were
recorded at the diffuse transmittance port of the integration
Table 1
Oligodeoxynucleotides used in BR mutagensis
Oligo No. Sequence (5Vto 3V)
(1) TTGGGCCCAGTACGCTGCTAACTGGCTG
(2) AAAAGGATCCGAGTACAAGACCGAGTG
(3) TTGCGCGCTACGCTAACTGGCTG
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sphere. Samples (0.5–0.8 OD/ml) were placed in a 3-ml
quartz cuvette (1-cm pathlength). The cuvette holder was
thermostatted at 20 jC using a Lauda RC20 circulator
(Brinkmann Instruments, Westbury, NY). Samples were
titrated by delivering (via a Microlab 500B dual syringe
pump, Hamilton, Reno, NV) 1–5 Al of 5 N HCl or 5 N
NaOH (in titration buffer) to the sample cuvette. The cuvette
was then capped and inverted 15 times. Following the
addition of titrant, the temperature was measured using a
temperature probe (Radiometer America, Westlake, OH).
When the temperature had equilibrated (steady reading for
20 s at 20F 0.3 jC) the pH was recorded on a Radiometer
PHM240 pH meter using a Radiometer calomel electrode
(pHC4000-8). At each pH value, the volume of titrant was
tabulated and absorbance spectra were collected from 800 to
250 nm at 1-nm intervals (2-nm slit width).
3. Results
3.1. Whole cell screen
BR concentration in the PM was quantified using a
Perkin Elmer E18 spectrophotometer and LabSphere RSA
150-mm light scattering attachment (e568
BR = 62,700 M  1
cm  1; [38]). Samples for spectral measurements were
prepared by dilution (in basal salts) of washed whole cells
to equivalent absorbance at 410 nm. The absorbance at 410
nm is due to a membrane-associated cytochrome and is
linearly proportional to the amount of total cells in the
sample whether BR was expressed (Fig. 1, solid circles) or
not (Fig. 1, open circles). BR accumulation was normalized
to equivalent numbers of cells for comparative analysis.
We then established the ability of reflectance spectro-
scopy to reproduce ground-state absorbance properties char-
acteristic of purified BR. Wild-type PM was applied to
nylon filters and equilibrated at neutral pH, as described for
the whole cells. For DA BR the kmax, determined by
reflectance spectroscopy, was 568 nm while the kmax was
558 nm for light-adapted (LA) BR (Fig. 2B). The same
analysis was performed for whole cells expressing wild-type
BR and the kmax determined were 566F 1 and 558F 3 nm
for the LA and DA, respectively (Fig. 2A), demonstrating
the precision and accuracy of the kmax determined from
whole cell pastes.
We then compared the pH-dependent absorbance proper-
ties of whole cells expressing D85N with those of PM
containing purified D85N (Fig. 3). In D85N, the absorbance
maximum of the spectral peak, which occurs between 550
and 650 nm (550–650kmax), is a weighted average of the
relative concentrations of the N (kmax = 570 nm) and O
(kmax = 615 nm) intermediates [26]. The average
550–650kmax
values, at pH 7.5, 9.0, and 10.5, agreed closely with those
obtained from purified protein (Table 2). No concentration
dependence was observed in the determination of 550–
650kmax for cells expressing D85N (data not shown). For
the whole cell paste samples the standard deviation of the
550 – 650kmax values increased with increasing pH. This
results from the M state (kmax = 410 nm) becoming increas-
ingly populated at high pH causing a decrease in amplitude
and broadening of the N/O peak. The 550–650kmax values
determined from the cell paste reflectance spectra reproduce
the corresponding values determined by visible absorbance
spectroscopy of PM containing purified D85N.
Subsequently, the spectral transitions of three D85N
second-site mutant whole cell pastes (D85N/T170C,
D85N/D96N, and D85N/R82Q) were compared with tran-
sitions obtained with purified protein (Fig. 4). Combining
these mutations with the D85N mutation allowed evaluation
of the homologous intermediate state transitions by ground-
state reflectance spectroscopy. As shown in Fig. 4A, D85N/
T170C has a red-shifted 550–650kmax at pH 7 and exhibits
significant concentrations of the N state at all pH values.
The pH dependence of the red shift is evident in the
Fig. 1. Reflectance spectroscopy of whole cells. 50-ml cultures of L33 and
L33 transgenically expressing BopI (wild type), were grown to stationary
phase. Cell pellets were collected and washed with basal salts and
resuspended to 50 ml. (A) Reflectance spectra of L33 cells expressing BopI
for the following volume dilutions with basal salts: (1) undiluted, (2) 80%
cell suspension:20% basal salts, (3) 40% cell suspension:60% basal salts,
(4) 10% cell suspension:90% basal salts. The absorbance maximum at 568
nm is due to BR; the absorbance maximum at 410 nm is due to a
membrane-associated cytochrome. (B) Reflectance measurements of
dilutions of L33 (solid symbols) and L33 expressing BopI (open symbols).
Triangles are measurements taken at 568 nm (BR absorbance maximum)
and circles are measurements taken at 410 nm (cytochrome absorbance
maximum). The cytochrome absorbance exhibits the same linear depend-
ence with cell number in the presence or absence of BR accumulation.
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reflectance spectroscopy of whole cell pastes and absorb-
ance spectroscopy of the purified protein sample.
The amino acids D96 and R82 are both located on helix
C and their role in light activated proton translocation is
well established through extensive study of the mutants
D96N and R82Q [39–43]. The D85N/R82Q double mutant
spectrum contains three spectral components in a pH-
dependent equilibrium (Fig. 4B, [44]). Unlike D85N, how-
ever, the presence of two isosbestic points indicates that the
spectral transitions occur with discrete pKa values. As the
pH is increased, the blue shift in the N/O peak occurs first,
followed by a decrease in amplitude, and the accumulation
of an absorbance peak at 410 nm (M). At neutral pH, the
550–650kmax determined from whole cells expressing D85N/
R82Q was very similar to that previously reported for
purified protein (e.g. 579 and 582 nm, respectively [44]).
This 550–650kmax, at neutral pH, is not as red-shifted as that
of D85N (Fig. 3, 610 nm), indicating that the O and N
species are both significantly populated at pH 7. At pH 9.0,
the whole cell spectrum was blue-shifted relative to the
spectrum at pH 7.5, consistent with increased accumulation
of N. The increase in amplitude of the M peak, however,
was only observed in the spectrum recorded at pH 10.5 and
above (Fig. 4B). The cell paste reflectance spectra demon-
strated that 550–650kmax of D85N/D96N only shifted by 10
nm as the pH was increased from 7.5 to 10.5, compared to a
Fig. 3. pH dependence of D85N spectra changes (100 mM NaCl, 20 mM
CAPS, 20 mM BTP, 20 mM, 20 mM NaH2PO4). (A) Reflectance spectra of
DA whole cells expressing D85N: (1) pH 7.0, (2) pH 9.0, (3) pH 10.5. (B)
Absorbance spectra of DA PM containing D85N. The spectra were
obtained at pH 7.13 (greatest amplitude at 615 nm and lowest amplitude at
410 nm), 7.51, 7.77, 7.95, 8.15, 8.34, 8.72, 9.06, 9.50, 9.94, 10.20, 10.42,
and 10.81 (lowest amplitude at 580 nm and greatest amplitude at 410 nm).
The spectral changes are completely reversible (data not shown).
Table 2
Comparison of kmax (nm) values determined by reflectance spectroscopy of
whole cell pastes and purified protein samples
D85N sample pH 7.5 pH 9.0 pH 10.5
Whole cells 615F 1 594F 4 582F 7
Purified protein 613 595 571
Fig. 2. Spectral changes during light-adaptation for wild-type BR. Whole
cells, or purified PM, were coated on to nylon filter paper by vacuum.
Samples were DA at room temperature for 5 days and subsequently LA by
exposure to light greater than 500 nm for 20 min. (A) Reflectance spectra:
1, DA wild-type whole cells; 2, LA wild-type whole cells. (B) Reflectance
spectra: 1, DA wild-type PM; 2, LA wild-type PM.
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32-nm shift in D85N (Fig. 4B). The change in N/O peak
height is f10%, greater for D85N/D96N than for D85N,
consistent with increased M accumulation in the double
mutant.
4. Discussion
We have developed a cell paste reflectance screen to
expedite the analysis of the numbers of BR mutants that can
be generated by random and semi-random mutagenesis.
This report demonstrates the precision and accuracy
achieved by ground-state reflectance analysis of solid sam-
ples, prepared from as little as 5 ml of cell culture, and
without the need for BR purification. We first validated the
approach by analysis of the LA and DA states of wild-type
BR and then by analysis of pH-dependent ground-state
transitions of four site-directed mutants, D85N, D85N/
T170C, D85N/D96N, and D85N/R82Q.
We used the single-site BR mutant D85N to probe
ground-state transitions that are close homologues of the
reprotonation phase of light-induced proton pumping
[26,45]. The protonation-state of aspartate 85 plays a central
role in the conformational changes and linked proton move-
ments. The use of the D85N mutant was the key since the
neutral side chain group of D85 effectively ‘‘permanently’’
protonated D85. Uncoupling the pKa of D85 from the BR
mechanism restricted the available conformational space to
transitions that normally contained a protonated D85. In the
absence of photoexcitation, homologues of the M, N, and O
states exist in equilibrium and their relative concentrations
are sensitive to bulk solvent proton activity. At neutral pH,
D85N exists as an O-like species (blue in color). As the pH
is raised, two additional chromophoric species, an N-like
species (purple in color) and an M-like species (yellow in
color), become populated at high pH [26]. Thus, in the
ground-state, the D85N mutant has trapped homologues of
the M, N, and O intermediates. The intermediate state
transitions of the single-site mutants T170C, D96N, R82Q
exhibit defects in the reprotonation mechanism, and we
anticipate that similar defects will be observed with these
mutations in the background of the D85N transitions.
Reflectance spectra of D85N/T170C whole cell pastes
indicate significant N accumulation at neutral pH. Indeed, N
is apparent at all pH. Threonine 170 is located in the F helix
and its side chain participates in forming the cytoplasmic
proton channel at the level of the position of D96. In the
reprotonation phase of the photocycle, D96 donates its
proton to the Schiff base during the decay of M. Mutations
in the cytoplasmic side of the proton channel have previ-
ously been shown to effect the kinetics of N formation,
possibly by altering the hydration of the channel and D96
[46]. The single-site mutations T49V, F219L, and F171C
decreased the pKa of D96 so that the ground-state confor-
mation exhibits N-like character [47]. In addition, malei-
mide-labeled T170C possessed a photocycle characterized
by accelerated M decay and slow decay of N resulting in its
accumulation [46,48]. The transitions observed in the whole
cell pastes containing D85N/T170C correspond well with
spectral phenotypes previously reported and support the
hypothesis that amino acid interactions in the cytoplasmic
portion of the proton channel regulate the pKa of D96 and
the accumulation of N (Fig. 4, [44,49,50]).
Reflectance analysis of D85N/R82Q demonstrates that a
purple (N) and yellow (M) species form at pH values similar
to those observed for the purified material [44] and the
accumulation of N and M proceed with different pKa’s (e.g.
two isosbestic points are evident in the spectral transitions,
Fig. 4). In the single-site mutant D85N, M and N are in rapid
equilibrium and the transition between them is pH-independ-
ent (Martinez and Turner, unpublished), consistent with the
observation of a single isosbestic point (Fig. 3). R82 is
situated a hydrophilic pocket of the extramembranous half-
Fig. 4. pH dependence of D85N second-site mutant absorbance spectra in
100 mM NaCl, 20 mM CAPS, 20 mM BTP, 20 mM, 20 mM NaH2PO4. (A)
Reflectance spectra of DAwhole cells expressing D85N/T170C; (1) pH 7.0,
(2) pH 9.0, (3) pH 10.5. (B) Absorbance spectra of DA PM containing
D85N/T170C. The spectra were obtained at pH 7.28 (greatest amplitude at
615 nm and lowest amplitude at 410 nm), 7.52, 7.90, 8.00, 8.48, 9.03, 9.50,
9.92, 10.46, and 11.02. (C) Reflectance spectra of DA whole cells
expressing D85N/R82Q; (1) pH 7.0, (2) pH 9.0, (3) pH 10.5. (D)
Absorbance spectra of DA PM containing D85N/R82Q. The spectra were
obtained at pH 7.11, 7.51, 8.02, 8.54, 8.93, 9.24, 9.70, 10.12, 10.90, and
11.22. (E) Reflectance spectra of DA whole cells expressing D85N/D96N;
(1) pH 7.0, (2) pH 9.0, (3) pH 10.5. (F) Absorbance spectra of DA PM
containing D85N/D96N. The spectra were obtained at pH 6.75, 7.26, 7.45,
7.75, 8.05, 8.22, 8.44, 8.86, 9.08, 9.22, 9.53, 9.75, and 10.97.
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channel and in numerous BR structures has been identified at
variable distances from D85, D212, E204, and structured
waters [5–8,29,51]. Consistent with its potential for forming
a multitude of intramolecular contacts, R82 plays a number
of critical roles in light-induced BR proton transduction.
Mutation of R82 has been shown to affect the linkage
between the pKa’s of D85 and the PRG(s) in both the ground
and M states [44,52]. In the ground-state the R82Q mutation
raised the pKa of D85 from f2.2 to near 7 and lead to
significant accumulation of a blue species [40,42,53,54].
R82A and R82Q were shown to have reduced proton
pumping efficiencies and a perturbed rate for the back
reaction from N to M. The D85N/R82Q ground-state tran-
sitions identified a defect that corresponds closely with that
observed in photo-kinetic studies and indicates a role for R82
in the accumulation of the M state.
Following photoexcitation, at neutral pH, the D96N
single-site mutant has a slow M decay resulting in accumu-
lation of the M intermediate [41]. X-ray diffraction of D85N/
D96N revealed that, at neutral pH, the double mutant has a
conformation like that of D85N at alkaline pH [49] (e.g. an
M homologue is present in both mutants). Unlike D85N, the
N intermediate does not form as the pH is raised [24,55]. We
therefore predicted that no shift in the 550–650kmax would be
observed as pH was increased in the reflectance spectra of
D85N/D96N whole cell pastes. In addition, due to the
decrease in the pKa of the Schiff base, M was predicted to
accumulate at lower pH values. The whole cell reflectance
analysis is consistent with both predictions and supports the
need for D96 deprotonation in the accumulation of the N
state.
In sum, there is a clear phenotypic consensus on compar-
ing spectral phenotypes of PM containing purified BR and
the reflectance spectroscopy of the whole cell pastes. The
phenotypes assigned to the D85N second-site mutants using
the whole cell reflectance spectra correspond closely to the
phenotypes reported previously for both single- and double-
site mutants. This not only supports the use of the whole cell
reflectance spectra to monitor BR conformational transi-
tions; it illustrates the correspondence between the ground-
state pH-dependent transitions of D85N and the analogous
photocycle transitions of wild-type BR. Owing to the small
amount of sample required and the lack of requirement for
BR purification, this reflectance technique would be very
useful in high-throughput screening of large numbers of BR
mutants that can be generated by random and semi-random
mutagenesis. We have exploited ground-state transitions of
BR to establish this technique at equilibrium. In principle,
the technique can be modified for time-resolved applications
and our future effort will focus on that potential.
Spectroscopy of whole cell preparations will be useful as
a rapid screen for high-level protein expression by elimi-
nating the need for extensive pre-processing of samples.
Unfortunately, the scattering component dominates the UV
region of the reflectance spectroscopy so that useful chro-
mophoric signatures will only be available in the visible and
IR regions. This approach will have immediate application
to screening and quantitative analysis of microbial cultures,
producing proteins with endogenous chromophores such as
cytochromes, or proteins that can be derivatized with
exogenous chromophores during preparation of cell pastes.
Indeed, recent work by McGovern et al. [56] demonstrated
that quantitative analysis of protein expression from E. coli
cell pastes could be accomplished by a combination of
various spectroscopy and ‘‘supervised learning’’ method-
ologies. A major conclusion of that work was that applica-
tion of multivariate analytical methods allowed reliable
quantification from spectra that had significant contribu-
tions from components other than the target species. The
system we describe takes advantage of the intense absorb-
ance of BR in the visible absorbance region such that
modeling is not required for species quantification. We
have recently demonstrated the utility of this cell paste-
reflectance strategy by analysis of the pH-dependent spec-
tral transition of 59 BR mutants, generated during a
cysteine-scanning mutagenesis of two of the seven BR
transmembrane helices [45].
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